Market Overview:
The global abiraterone acetate drugs market is expected to register a CAGR of XX% during the forecast period 2018-2030. The growth in this market can be attributed to factors such as, rising prevalence of prostate cancer, increasing demand for novel therapies and growing awareness about prostate cancer. Based on type, the global abiraterone acetate drugs market is segmented into 125 mg, 250 mg and 500 mg. The 250 mg segment is expected to account for the largest share of the global abiraterone acetate drugs market in 2018. This can be attributed to its higher efficacy as compared to other dosages and growing demand for novel therapies. Based on application, the global abiraterone acetate drugs market is segmented into online pharmacy and offline pharmacy. The offline pharmacy segment is expected to account for a larger share of the global abiraterone acetate drugs market in 2018 owing to higher adoption rates in developing countries.
Product Definition:
Abiraterone acetate is a drug used to treat prostate cancer. It works by blocking the production of testosterone in the body. This helps to shrink the tumor and slow its growth.
125 mg:
125 mg is used for the treatment of prostate cancer. It works by slowing down or decreasing the growth of cancer cells in the body. 125 mg is a form of abiraterone acetate, which is an anti-androgenic drug that decreases production of dihydrotestosterone (DHT) by the adrenal glands and scalp hair follicles in men as well as women.
250 mg:
250 mg is used in the treatment of prostate cancer. It is also used as a part of combination therapy with chemotherapy for patients suffering from advanced or metastatic breast cancer, and as a monotherapy for castration-resistant prostate cancer.
Global Abiraterone Acetate Drugs Market, by Type (Powder For Injection, Powder For Oral Solution), 2018 - 2024 -> The global abiraterone acetate drugs market was valued at USD 745 million in 2015.
Application Insights:
The online pharmacy application segment dominated the global abiraterone acetate drugs market in 2017. This is attributed to factors such as an increase in internet users, growing use of electronic medical records and rising healthcare costs. In addition, a rise in awareness regarding generic medicines is expected to boost the growth of this segment over the forecast period.
Offline pharmacies are anticipated to witness significant growth owing to increasing penetration of these facilities across developing countries such as India and China. Moreover, governments are making efforts towards ensuring better distribution network for pharmaceutical companies which will eventually benefit offline pharmacies too. For instance, Pfizer Inc has signed an agreement with Sun Pharmaceutical Industries Ltd for selling its products through this channel at competitive prices within India only available from Pfizer Inc's website (www.com).
Regional Analysis:
North America was the largest regional market in 2017 owing to the presence of a large number of companies and availability of advanced healthcare infrastructure. The region is expected to maintain its dominance during the forecast period due to increasing geriatric population, which is prone to cancer and other diseases. Rising awareness about abiraterone acetate among patients from North America has been fueling growth in this region.
Asia Pacific is projected to be one of the fastest-growing regions over the forecast period owing to rising disposable income, improving economic conditions, expanding patient pool & awareness campaigns by regulatory bodies for effective utilization of drugs in various applications. Growing demand for generic versions as well as brand name products will also contribute toward growth over this period. Abiraterone acetate 125 mg tablets are available OTC in Japan; however, it will soon be out-of-stock due with new drug application (NDA) approval by Japanese FDA for higher dosage strength tablet forms (250 & 500 mg).
Growth Factors:
- Increasing incidence of prostate cancer: The incidence of prostate cancer is increasing globally. This will drive the demand for abiraterone acetate drugs in the coming years.
- Growing awareness about prostate cancer: There is a growing awareness among people about prostate cancer and its treatment options, including abiraterone acetate drugs. This will help to boost the demand for these drugs in the coming years.
- Rising adoption of targeted therapies: The adoption of targeted therapies for treating prostate cancer is rising rapidly across the globe. This will fuel the demand for abiraterone acetate drugs in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Abiraterone Acetate Drugs Market Research Report
By Type
125 mg, 250 mg, 500 mg
By Application
Online Pharmacy, Offline Pharmacy
By Companies
Janssen Global Services, Dr Reddy's Laboratories, Amneal Pharmaceuticals, Avalon Pharma, Sterling, ScinoPharm Taiwan, Hetero Healthcare, Aurisco Pharmaceutical, Teva Pharmaceutical Industries, Qilu Pharmaceutical, Janssen Global Services, Mylan N.V., Sun Pharmaceutical Industries, Hikma Pharmaceuticals USA, Novadoz Pharmaceuticals, Msn Laboratories Private, Apotex, NorthStar Rx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Abiraterone Acetate Drugs Market Report Segments:
The global Abiraterone Acetate Drugs market is segmented on the basis of:
Types
125 mg, 250 mg, 500 mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online Pharmacy, Offline Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Janssen Global Services
- Dr Reddy's Laboratories
- Amneal Pharmaceuticals
- Avalon Pharma
- Sterling
- ScinoPharm Taiwan
- Hetero Healthcare
- Aurisco Pharmaceutical
- Teva Pharmaceutical Industries
- Qilu Pharmaceutical
- Janssen Global Services
- Mylan N.V.
- Sun Pharmaceutical Industries
- Hikma Pharmaceuticals USA
- Novadoz Pharmaceuticals
- Msn Laboratories Private
- Apotex
- NorthStar Rx
Highlights of The Abiraterone Acetate Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 125 mg
- 250 mg
- 500 mg
- By Application:
- Online Pharmacy
- Offline Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Abiraterone Acetate Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Abiraterone acetate is a medication used to treat prostate cancer. It works by stopping the growth of cancer cells in the body.
Some of the major companies in the abiraterone acetate drugs market are Janssen Global Services, Dr Reddy's Laboratories, Amneal Pharmaceuticals, Avalon Pharma, Sterling, ScinoPharm Taiwan, Hetero Healthcare, Aurisco Pharmaceutical, Teva Pharmaceutical Industries, Qilu Pharmaceutical, Janssen Global Services, Mylan N.V., Sun Pharmaceutical Industries, Hikma Pharmaceuticals USA, Novadoz Pharmaceuticals, Msn Laboratories Private, Apotex, NorthStar Rx.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Abiraterone Acetate Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Abiraterone Acetate Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Abiraterone Acetate Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Abiraterone Acetate Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Abiraterone Acetate Drugs Market Size & Forecast, 2018-2028
4.5.1 Abiraterone Acetate Drugs Market Size and Y-o-Y Growth
4.5.2 Abiraterone Acetate Drugs Market Absolute $ Opportunity
Chapter 5 Global Abiraterone Acetate Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Abiraterone Acetate Drugs Market Size Forecast by Type
5.2.1 125 mg
5.2.2 250 mg
5.2.3 500 mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Abiraterone Acetate Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Abiraterone Acetate Drugs Market Size Forecast by Applications
6.2.1 Online Pharmacy
6.2.2 Offline Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Abiraterone Acetate Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Abiraterone Acetate Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Abiraterone Acetate Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Abiraterone Acetate Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Abiraterone Acetate Drugs Market Size Forecast by Type
9.6.1 125 mg
9.6.2 250 mg
9.6.3 500 mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Abiraterone Acetate Drugs Market Size Forecast by Applications
9.10.1 Online Pharmacy
9.10.2 Offline Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Abiraterone Acetate Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Abiraterone Acetate Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Abiraterone Acetate Drugs Market Size Forecast by Type
10.6.1 125 mg
10.6.2 250 mg
10.6.3 500 mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Abiraterone Acetate Drugs Market Size Forecast by Applications
10.10.1 Online Pharmacy
10.10.2 Offline Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Abiraterone Acetate Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Abiraterone Acetate Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Abiraterone Acetate Drugs Market Size Forecast by Type
11.6.1 125 mg
11.6.2 250 mg
11.6.3 500 mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Abiraterone Acetate Drugs Market Size Forecast by Applications
11.10.1 Online Pharmacy
11.10.2 Offline Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Abiraterone Acetate Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Abiraterone Acetate Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Abiraterone Acetate Drugs Market Size Forecast by Type
12.6.1 125 mg
12.6.2 250 mg
12.6.3 500 mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Abiraterone Acetate Drugs Market Size Forecast by Applications
12.10.1 Online Pharmacy
12.10.2 Offline Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Abiraterone Acetate Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Abiraterone Acetate Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Abiraterone Acetate Drugs Market Size Forecast by Type
13.6.1 125 mg
13.6.2 250 mg
13.6.3 500 mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Abiraterone Acetate Drugs Market Size Forecast by Applications
13.10.1 Online Pharmacy
13.10.2 Offline Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Abiraterone Acetate Drugs Market: Competitive Dashboard
14.2 Global Abiraterone Acetate Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Janssen Global Services
14.3.2 Dr Reddy's Laboratories
14.3.3 Amneal Pharmaceuticals
14.3.4 Avalon Pharma
14.3.5 Sterling
14.3.6 ScinoPharm Taiwan
14.3.7 Hetero Healthcare
14.3.8 Aurisco Pharmaceutical
14.3.9 Teva Pharmaceutical Industries
14.3.10 Qilu Pharmaceutical
14.3.11 Janssen Global Services
14.3.12 Mylan N.V.
14.3.13 Sun Pharmaceutical Industries
14.3.14 Hikma Pharmaceuticals USA
14.3.15 Novadoz Pharmaceuticals
14.3.16 Msn Laboratories Private
14.3.17 Apotex
14.3.18 NorthStar Rx
